Device Trial Radar · NCT05313984
OptiLUTS Part C: the Development of a Symptom Assessment Tool in Sacral Neuromodulation.
Last checked: Nov 19, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
93
Actual
Start
Mar 1, 2018
Primary completion
Dec 1, 2021
Study completion Dec 31, 2021
Sponsor
- Lead sponsor
- University Hospital, GhentAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medtronic
- First posted
- Apr 6, 2022
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Sacral neuromodulation (SNM) is a two-staged 2nd-line therapy for therapy-resistant LUTS and fecal incontinence. Currently, the assessment of symptoms at baseline and after stage I is directed towards a discipline related evaluation. The OptiLUTS trial strives for a more holistic approach, taking all pelvic floor dysfunctions into account. A holistic assessment tool will be developed and SNM-care pathway will be set-up.
Conditions
- Overactive Bladder Syndrome
- Urinary Retention
- Dysfunctional Voiding
- Fecal Incontinence
- Fowler Syndrome
Interventions
Sacral neuromodulationDevice
Sacral neuromodulation: the 2-staged tined lead procedure. (Interstim II therapy, Medtronic). Stage I: Placement of a tined-lead electrode. 2 - 4 weeks test phase. Stage II: Placement of an implantable pulse generator.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Implantation ratioTime frame: Through study completion, an average of 3 years
- True success ratioTime frame: Through study completion, an average of 3 years
- False positive ratioTime frame: One month after definitive implant.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Urology, Ghent University Hospital
Ghent, Belgium
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.